GENETIC MARKERS FOR COGNITIVE DECLINE IN THE ELDERLY

Authors

  • Cristina Solé-Padullés
  • Imma C. Clemente
  • David Bartrés-Faz
Keywords: cognitive ageing, genetic polymorphisms, Age Associated Memory Impairment (AAMI), Mild Cognitive Impairment (MCI), Magnetic Resonance, Alzheimer disease

Abstract

The present paper reviews the studies carried out regarding genetic markers for cognitive decline in the elderly. Specifically, the role of several polymorphisms is studied in the entities of Age Associated Memory Impairment (AAMI) and Mild Cognitive Impairment (MCI), which are considered high-risk conditions for dementia. There are several candiate genes, whose genetic variations appear to modulate some aspect of cognitive functioning, cerebral structure or brain activity within the elder. These genetic polymorphisms are, amongst others, the ones codifying for the following genes: apolipoproteins E and C1, angiotensin-converting enzyme (ACE), endothelial oxide nitric synthase (NOS3), dopamine D2 receptor (DRD2) and serotonin 2A receptor (5HT2A). Behavioural genetics of cognitive ageing requires future methodological developments to investigate with higher reliability the association between genetic variations and neuropsychological function.

Downloads

Download data is not yet available.

Author Biographies

Cristina Solé-Padullés

Universitat de Barcelona

Imma C. Clemente

Universitat de Barcelona

David Bartrés-Faz

Universitat de Barcelona
How to Cite
Solé-Padullés, C., Clemente, I. C., & Bartrés-Faz, D. (2004). GENETIC MARKERS FOR COGNITIVE DECLINE IN THE ELDERLY. Anales de Psicología / Annals of Psychology, 20(2), 187–204. Retrieved from https://revistas.um.es/analesps/article/view/27321
Issue
Section
Monographic issue: current lines in neuropsychology